ADA and neoplasm: Collectively, our data suggest that overexpression of FOXO1-ADA in CAR T cells contributes to enhanced in vivo anti-tumour activity by promoting T cell polyfunctionality, proliferation and mitochondrial biogenesis to support effector functions.